A Study of RVT-1401 in Myasthenia Gravis (MG) Patients

NCT03863080 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Myasthenia Gravis

Interventions

DRUG: RVT-1401
DRUG: Placebo

Sponsor

Immunovant Sciences GmbH